CareDx Inc
Healthcare · USD
Price
$18.31
Cap
$911M
Earnings
0/1 beat
30d Trend
+2%
Upper half of range — momentum is positive
Target range: $21 – $40 (consensus: $27.33)
Consensus: Hold
Earnings history
Q4 2025
MISS
0.12 vs 0.23
Key macro factors
Healthcare Reimbursement Policies: Changes in reimbursement policies, such as the anticipated negative revenue impact of $7.5 million in CareDx's 2026 guidance due to potential shifts in reimbursement for testing services, directly affect the company's revenue and profitability.
Broader Economic Conditions: The IMF's projected downgrade of global growth forecasts amidst the Middle East conflict could lead to tighter economic conditions. This may impact overall healthcare spending and patient access to advanced diagnostic solutions, indirectly affecting demand for CareDx's services.
Inflation and Operating Costs: Rising oil prices and general inflationary pressures, driven by the Middle East conflict, can increase operational expenses for healthcare companies like CareDx. Higher costs for supplies, logistics, and labor could pressure profit margins for diagnostic services.
CareDx, Inc. is a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers worldwide. It offers non-invasive molecular testing services for heart, kidney, and lung transplants, laboratory products, and digital health technologies across the pre- and post-transplant patient journey.
QUANT SCORE
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.